As of 2:31 PM on the 26th, Celltrion is trading at 314,000 KRW, up 2.11% from the previous day. This marks a 9.98% increase compared to March 10. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have net sold 37,689 shares of Celltrion, while institutions have net bought 11,000 shares, according to provisional data. Over the past five days, individual investors have net sold 27,760 shares, foreigners have net sold 799 shares, and institutions have net bought 34,495 shares respectively.


On March 17, Celltrion was a market topic with the headline '210 billion KRW scale "Truxima" supply contract... stock price on a downward trend.'


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing